| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Vera Therapeutics, Inc. | Chief Commercial Officer | Class A Common Stock | 64,218 | $2,696,122 | $41.98 | 23 Feb 2026 | Direct |
| Vera Therapeutics, Inc. | Chief Commercial Officer | Stock Option (right to buy) | 40,000 | 04 Feb 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| VERA | Vera Therapeutics, Inc. | 23 Feb 2026 | 1 | -$66,419 | 4 | Chief Commercial Officer | 25 Feb 2026, 19:53 |
| VERA | Vera Therapeutics, Inc. | 04 Feb 2026 | 2 | $0 | 4 | Chief Commercial Officer | 06 Feb 2026, 20:00 |
| VERA | Vera Therapeutics, Inc. | 20 Jan 2026 | 0 | $0 | 3 | Chief Commercial Officer | 30 Jan 2026, 16:05 |